Properties of TAN-67, a nonpeptide δ-opioid receptor agonist, at cloned human δ-and μ-opioid receptors

https://doi.org/10.1016/0922-4106(95)90134-5Get rights and content

Abstract

2-methyl-4a α(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a α-octahydro-quinolino[2,3,3-g]isoquinoline (TAN-67) is a nonpeptidic δ-opioid receptor agonist. This report describes its receptor binding affinity and agonist potency at human and mouse δ and μ-opioid receptors. The binding affinities of TAN-67 and the cyclic enkephalin analog, [D-Pen2, 4′-Cl-Phe4, D-Pen5]enkephalin (pCl-DPDPE) were measured by the radioligand binding inhibition studies at mouse and human variants of the δ and μ-opioid receptor using [3H]Naltrindole and [3H]D-Phe-Cys  Tyr  D  Trp  Orn  Thr  Pen-Thr-NH2, respectively. TAN-67 showed high binding affinity (Ki = 0.647 nM) at the human δ-opioid receptor and high δ-opioid receptor binding selectivity (> 1000-fold) relative to the human μ-opioid receptor. TAN-67 also showed high potency (EC50 = 1.72 nM) for the inhibition of forskolin-stimulated cAMP accumulation at human δ-opioid receptors expressed by intact Chinese hamster ovary cells but low potency (EC50 = 1520 nM) at human μ-opioid receptors expressed by intact B82 mouse fibroblast cells. The results show that TAN-67 has similar binding affinities, selectivity and potencies as pCl-DPDPE at human δ and μ-opioid receptors. These results combined with the nonpeptidic structure of TAN-67 suggest that this compound has therapeutic potential as a δ-opioid receptor agonist.

References (23)

  • Y.-C. Cheng et al.

    Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC-50) of an enzymatic reaction

    Biochem. Pharmacol.

    (1973)
  • Cited by (35)

    • Activation of peripheral δ<inf>2</inf>-opioid receptor prevents reperfusion heart injury

      2021, European Journal of Pharmacology
      Citation Excerpt :

      These data were confirmed by other investigators (Zeng et al., 2011), who found that TAN-67 at dose of 10 mg/kg prevents ischemia/reperfusion injury of the heart via opioid δ1-receptor stimulation. The use of such a high dose by both groups of investigators was surprising because TAN-67 exhibits a high affinity for opioid δ-receptor (Knapp et al., 1995; Gross, 2003). We hypothesize that the infarct sparing effect of TAN-67 may involve the activation of central opioid δ1-receptor(s) because of the limited passage through the blood-brain barrier, therefore, such a high dose of the drug was required.

    • Research and development of κ opioid receptor agonists and δ opioid receptor agonists

      2020, Pharmacology and Therapeutics
      Citation Excerpt :

      The (±)-TAN-67 produced an NTI-reversible inhibitory effect on the contraction of mouse vas deferens with an IC50 value of 6.61 nM, suggesting that the (±)-TAN-67 showed agonistic activity via the DOP. The (±)-TAN-67 also showed a robust agonistic activity (EC50 = 1.72 nM) for the inhibition of forskolin-stimulated cAMP accumulation at the human DOP expressed by intact Chinese hamster ovary (CHO) cells, but low potency (EC50 = 1520 nM) at the human MOP receptor expressed by intact B82 mouse fibroblast cells (Knapp et al., 1995). These in vitro results from assays using human DOPs and MOPs showed that the (±)-TAN-67 has a similar binding affinity, selectivity, and potency as DPDPE, a representative prototype peptidic DOP ligand (Knapp et al., 1995).

    • The delta opioid receptor tool box

      2016, Neuroscience
      Citation Excerpt :

      Indeed, no analgesic effects to ARM390 were observed in the lactic acid-induced stretching assay in rats after its intraperitoneal administration (Negus et al., 2012). TAN-67 is a morphinan derivative with high selectivity for the delta opioid receptor (Knapp et al., 1995). Although the racemic (+/−)-TAN-67 showed no analgesic activity, its enantiomer (−)-TAN-67 is highly effective (Nagase et al., 2001).

    • Kappa and delta opioid receptor signaling is augmented in the failing heart

      2009, Journal of Molecular and Cellular Cardiology
      Citation Excerpt :

      Fentanyl, concentrations were between 100 pM and 10 μM. Agonist concentrations were based on receptor selectivity [13,14] to assure that drugs would act preferentially at the desired receptor. In addition, preliminary concentration response curves were performed to insure an effective range of concentrations.

    View all citing articles on Scopus
    View full text